Hamada A. Mokhlis

631 citations
18 papers · 494 indexed · h-index 10
Topics
MicroRNA in disease regulation (6 papers)Cancer-related molecular mechanisms research (6 papers)Circular RNAs in diseases (4 papers)

In The Last Decade

Hamada A. Mokhlis

17 papers receiving 492 citations

Peers

Hamada A. Mokhlis
Comparison fields: 5 of 74
  • Molecular Biology 311
  • Cancer Research 226
  • Oncology 63
  • Complementary and alternative medicine 40
  • Pathology and Forensic Medicine 35
Replace Ke Shen with:
Ke Shen China
Yujie Sun China
Mingning Qiu China
Shilpi Chattopadhyay India
Bei Zhou China
Ju Wang China
Deblina Guha India
Arturo Cruz-Salgado Mexico
Mu-Xin Wei China
Xiu Cheng China
Hamada A. Mokhlis relative to Ke Shen China Ke Shen's profile →
Citations per field
00.5×1.5×2.5×
Ke Shen · 1×
Citations per year

Countries citing papers authored by Hamada A. Mokhlis

Since Specialization
Citations

This map shows the geographic impact of Hamada A. Mokhlis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamada A. Mokhlis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamada A. Mokhlis more than expected).

Fields of papers citing papers by Hamada A. Mokhlis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamada A. Mokhlis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamada A. Mokhlis. The network helps show where Hamada A. Mokhlis may publish in the future.

Co-authorship network of co-authors of Hamada A. Mokhlis

This figure shows the co-authorship network connecting the top 25 collaborators of Hamada A. Mokhlis. A scholar is included among the top collaborators of Hamada A. Mokhlis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamada A. Mokhlis. Hamada A. Mokhlis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 2
5 47
6 38
7 63
8 6
9 9
10 18
11 36
12 41
13 1
14 74
15 28
16 67
17 3
18 58

About Hamada A. Mokhlis

Hamada A. Mokhlis is a scholar working on Cancer Research, Toxicology and Oncology, having authored 18 papers that have together received 494 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (226 citations), Toxicology (26 citations) and Complementary and alternative medicine (40 citations). Hamada A. Mokhlis has collaborated with scholars based in Egypt, United States and Türkiye. Frequent co-authors include Nermin Kahraman, Bülent Özpolat, Nashwa Kabil, Recep Bayraktar, Gabriel Lopez‐Berestein, George A. Călin, Ahmed S. Doghish, Ahmed Ismail, Pınar Kanlikilicer and Cristina Ivan. Their work appears in journals such as Cancer Research, Oncogene and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026